Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) Net Margin (2024 - 2026)

Updated

Abivax (ABVX) recorded Net Margin of -259.01% in Q2 2026, up 608.94 percentage points from -867.95% a year earlier.

Analysis

Abivax (ABVX) Net Margin (2024 - 2026) Analysis & Trends

Starting with Q1 2024, Abivax's Net Margin history includes 8 quarters.

  • Quarterly Net Margin has ranged from -4541.87% in Q4 2024 to -159.07% in Q3 2025 over the past five years.
  • On a year-over-year basis, Net Margin rose in two of the last four quarters, with an average year-over-year change of -317.69 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Abivax 7.07 Bn 4.69 Bn - -259.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -259.01%
Mar 31, 2026 -895.99%
Sep 30, 2025 -159.07%
Jun 30, 2025 -863.76%
Mar 31, 2025 -690.71%
Sep 30, 2024 -528.13%
Jun 30, 2024 -415.42%
Mar 31, 2024 -633.94%
API Access

Abivax Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY